Zinc alpha 2-glycoprotein associates with features of plaque stability in patients with carotid atherosclerosis.

Competing Interests: Declaration of competing interest LL and GGC are coinventors on the International Patent (WO/2020/226993) filed in April 2020 and relating to the use of antibodies which specifically bind IL-1α to reduce various sequelae of ischemia–reperfusion injury to the central nervous system. The other authors report no conflict of interest.